Myocardial performance in conscious streptozotocin diabetic rats.
about
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyNeointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcineA thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin IIGlycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatmentEnhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion.L-glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats.Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic ratsAugmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsDietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathioneThe afterload-dependent peak efficiency of the isolated working rat heart is unaffected by streptozotocin-induced diabetes.Attenuated dopaminergic tone in the paraventricular nucleus contributing to sympathoexcitation in rats with Type 2 diabetesMerit of ginseng in the treatment of heart failure in type 1-like diabetic rats.Cardioprotective Activity of Pongamia pinnata in Streptozotocin-Nicotinamide Induced Diabetic Rats.Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications.Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents.A Novel Approach for Oral Delivery of Insulin via Desmodium gangeticum Aqueous Root Extract.Targeting apoptosis in the heart of streptozotocin-induced diabetic rats.The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model.Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms.Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes.Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.Effects of the association of diabetes and pulmonary emphysema on cardiac structure and function in rats
P2860
Q26799594-9DDC12A0-7566-473B-A7BD-5B9D63FABCF9Q28212482-04366EB4-DD61-4285-80DE-88698E4EB772Q28583200-0BF677A1-F7D3-401B-BEBD-129C10DAF28EQ34517974-CFDB76EE-055C-474B-A7C7-9D4F47EF875AQ34636120-CA406DE4-738C-4ABB-973A-FD482F224418Q35126658-6CF3BF80-0D8E-46D1-9652-214A4104FB1DQ35875059-DE08BBBC-8B21-425F-8ED6-BB4FB7A789C5Q36337283-C3B93DE2-011A-41DC-9E0C-FABE649755AEQ36741562-EE998621-7874-416C-A351-62C5F239C850Q36971492-C840B6E2-94C0-449E-80F5-347D280F2E32Q37001203-CC599CE5-120C-46FE-831C-1ABFA3523CF0Q37011769-06F027A4-F8D2-4A36-8755-99205B06A1DEQ37199766-B6226F20-CBE7-4105-B94F-D4D615EE121EQ37564467-20B6D6B8-33E1-41A8-BE4D-DB517B1F9E24Q37578164-4B3AADFA-8B87-4486-878E-DFAC3D027F18Q37686746-FB25572F-6B76-4963-A5B3-63796524896BQ39994083-FF9F34F1-D215-4291-916B-E739D42E84FBQ41921965-D57A56C3-F31B-4583-B751-95EB57CC3499Q42010873-CEEC26FE-E976-40F9-803C-C010867D549EQ42251233-53CF6A74-E171-4E84-A9BE-C9E0DF95F0C7Q43172662-2CE25827-5181-44FD-867E-C33243E421C8Q43269514-A229164C-990A-4C23-B60D-BCCD0CB18E86Q44702438-EA8EEC1D-E53F-43A3-97D0-A0D89DB6E828Q48162668-289BAC0E-7492-4DCE-9F41-163B43E40761Q49601942-517037B8-350D-4414-9168-6FDF648FA4E2Q58853825-FBBA9EE8-293F-41AF-A861-F5122742498B
P2860
Myocardial performance in conscious streptozotocin diabetic rats.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Myocardial performance in conscious streptozotocin diabetic rats.
@ast
Myocardial performance in conscious streptozotocin diabetic rats.
@en
type
label
Myocardial performance in conscious streptozotocin diabetic rats.
@ast
Myocardial performance in conscious streptozotocin diabetic rats.
@en
prefLabel
Myocardial performance in conscious streptozotocin diabetic rats.
@ast
Myocardial performance in conscious streptozotocin diabetic rats.
@en
P2093
P2860
P356
P1476
Myocardial performance in conscious streptozotocin diabetic rats.
@en
P2093
Giulianna R Borges
Helio C Salgado
Mauro de Oliveira
Rubens Fazan
P2860
P2888
P356
10.1186/1475-2840-5-26
P407
P577
2006-12-04T00:00:00Z
P5875
P6179
1044537753